quotient sciences clinical content

31. Pediatric Dosage Form Development: Taste/PK Assessments, Clinical Supplies And Commercial Manufacturing 6/8/2022

    Given that in-house Large Pharma and the CMO service sector have traditionally focused on high-volume and low-variation drug products, there is an emerging industry need for smaller-scale, batch manufacturing.

32. Pediatric Dosage Form Development: Program Design And Formulation Development 6/8/2022

    Explore key considerations to successfully bridge from initial concept of pediatric program design and formulation development strategies into later stages of development and through to commercialization.

33. Accelerating The Development Of Orphan Drugs For Rare Diseases 4/18/2022

    Explore four principal CMC challenges for the developers of orphan drugs and the potential emerging solutions.

34. Miami Clinical Pharmacology Facility Tour 3/7/2022

    Our new, state-of-the-art compounding pharmacy supports the rapid and cost-effective preparation of dosage forms including oral solutions, suspensions, drug or powder in capsule or bottle, and sterile preparations.

35. A Phase I Study Allowing Clinical Screening Of Multiple Solubility-Enhancement Formulation Technologies 3/7/2022

    The study was designed to assess the clinical performance of prototype formulations, assess food effect and dose linearity of a selected formulation, and the impact on exposure in subjects taking proton pump inhibitors (PPI).

36. Early Development: Accelerating Molecules Through To Proof-Of-Concept 3/3/2022

    Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.

37. Accelerating The Development Of Oncology Medicines 3/3/2022

    Oncology drug development has seen a significant shift in focus, as molecule chemistries and drug technologies have improved. Explore five areas for consideration and the potential emerging solutions.

38. Pre-Formulation And Material Sciences 3/3/2022

    Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.

39. Accelerating Drug Product Development From Early Phase To Commercialization 3/3/2022

    This case study demonstrates rapid development, clinical assessment and commercial readiness of DRGT-46, a novel composition of Celecoxib, using integrated services.

40. Isotope Labelling 3/3/2022

    Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.